Your browser doesn't support javascript.
loading
Response to McGirr et al.'s Comment on "Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada".
Wilson, Michele R; Wasserman, Matt; Jadavji, Taj; Postma, Maarten; Breton, Marie-Claude; Peloquin, Francois; Earnshaw, Stephanie R; McDade, Cheryl; Sings, Heather L; Farkouh, Raymond.
Affiliation
  • Wilson MR; RTI Health Solutions, Research Triangle Park, NC, USA. mwilson@rti.org.
  • Wasserman M; Pfizer Inc., New York, NY, USA.
  • Jadavji T; Departments of Pediatrics, Microbiology, Immunology, and Infectious Diseases, Faculty of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada.
  • Postma M; Department of Pharmacy, University of Groningen, Groningen, The Netherlands.
  • Breton MC; Research Institute of Science in Healthy Aging and healthcaRE (SHARE), University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands.
  • Peloquin F; Pfizer Canada Inc., Kirkland, QC, Canada.
  • Earnshaw SR; Pfizer Canada Inc., Kirkland, QC, Canada.
  • McDade C; RTI Health Solutions, Research Triangle Park, NC, USA.
  • Sings HL; RTI Health Solutions, Research Triangle Park, NC, USA.
  • Farkouh R; Pfizer Inc., Collegeville, PA, USA.
Infect Dis Ther ; 7(4): 539-543, 2018 Dec.
Article in En | MEDLINE | ID: mdl-30411203

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation Language: En Journal: Infect Dis Ther Year: 2018 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation Language: En Journal: Infect Dis Ther Year: 2018 Document type: Article Affiliation country: Estados Unidos